Shandong Sinobioway Biomedicine Co Ltd (002581) — Long-term Investment Intensity
Shandong Sinobioway Biomedicine Co Ltd (002581) has a Long-term Investment Intensity of 13.6% as of September 2019. Long-term investments of CN¥528.81 Million represent 13.6% of total assets of CN¥3.88 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how aggressively does Shandong Sinobioway Biomedicine Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shandong Sinobioway Biomedicine Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Shandong Sinobioway Biomedicine Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 13.6%, reflecting long-term investments of CN¥528.81 Million against total assets of CN¥3.88 Billion CNY. Explore Shandong Sinobioway Biomedicine Co Ltd (002581) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Shandong Sinobioway Biomedicine Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Shandong Sinobioway Biomedicine Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 002581 stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 10.1% | CN¥434.74 Million | CN¥4.29 Billion | ▼ -1.2 pp |
| 2017 | 11.3% | CN¥453.22 Million | CN¥4.00 Billion | ▼ -1.8 pp |
| 2016 | 13.1% | CN¥353.01 Million | CN¥2.69 Billion | ▲ +4.3 pp |
| 2015 | 8.8% | CN¥212.50 Million | CN¥2.42 Billion | — |